Sign In
Buy AKBA
$0.97
+0.0333 (+3.56%)
At Close: Jun 03, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:30pm, Monday, 04'th May 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted eight newly-hired
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Wall Street Analysts Are Bullish on Top Healthcare Picks
02:41pm, Thursday, 30'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Genocea Biosciences (GNCA), Chemed (CHE) and BioMarin
What Kind Of Investor Owns Most Of Akebia Therapeutics, Inc. (NASDAQ:AKBA)?
10:14am, Thursday, 30'th Apr 2020
A look at the shareholders of Akebia Therapeutics, Inc. (NASDAQ:AKBA) can tell us which group is most powerful...
Akebia Therapeutics to Report First Quarter 2020 Financial Results and Discuss Recent Business Highlights
12:00pm, Tuesday, 28'th Apr 2020
Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced plans to r
Short Interest in Akebia Therapeutics Inc (NASDAQ:AKBA) Declines By 6.5%
09:44am, Wednesday, 22'nd Apr 2020
Akebia Therapeutics Inc (NASDAQ:AKBA) was the target of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 6,780,000 shares, a decreas
Akebia Therapeutics Inc (NASDAQ:AKBA) Position Increased by Geode Capital Management LLC
10:02am, Tuesday, 21'st Apr 2020
Geode Capital Management LLC raised its position in shares of Akebia Therapeutics Inc (NASDAQ:AKBA) by 5.0% in the fourth quarter, according to its most recent disclosure with the Securities and Excha
2 Small-Cap Stocks That Could Double Your Money
11:45am, Saturday, 18'th Apr 2020
Akebia Therapeutics and Satsuma Pharmaceuticals could both be big winners for early shareholders.
Nuveen Asset Management LLC Increases Stock Position in Akebia Therapeutics Inc (NASDAQ:AKBA)
09:08am, Saturday, 18'th Apr 2020
Nuveen Asset Management LLC grew its stake in shares of Akebia Therapeutics Inc (NASDAQ:AKBA) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securit
Does Akebia Therapeutics (NASDAQ:AKBA) Have A Healthy Balance Sheet?
10:44am, Friday, 17'th Apr 2020
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is Akebia Therapeutics (NASDAQ:AKBA) Using Debt In A Risky Way?
10:11am, Wednesday, 15'th Apr 2020
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Seth Klarman Dials Down Akebia Therapeutics Stake
04:26pm, Tuesday, 14'th Apr 2020
Renowned guru slims position in biotech company that focuses on kidney disease Continue reading...
Seth Klarman Dials Down Akebia Therapeutics Stake
03:29pm, Tuesday, 14'th Apr 2020
Seth Klarman Dials Down Akebia Therapeutics Stake, Stocks: AKBA,TBPH,TBIO,ATRA,GOSS,PRTK, Seth Klarman, release date:Apr 14, 2020
Akebia Therapeutics Inc (NASDAQ:AKBA) Stake Boosted by Renaissance Technologies LLC
09:30am, Monday, 13'th Apr 2020
Renaissance Technologies LLC increased its position in shares of Akebia Therapeutics Inc (NASDAQ:AKBA) by 219.0% during the 4th quarter, according to its most recent disclosure with the Securities and
